CINRYZE

Swiss trademark · 569778 · Word mark · In force

Register entry

Registration number
569778
Application number
64486/2007
Status
In force
Type
Word mark
Filed
Dec 20, 2007
Registered
Apr 1, 2008
Published
Apr 15, 2008
Protected until
Dec 20, 2027
Priority
21.06.2007 US
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für die Behandlung bei entzündlichen Prozessen, nämlich hereditären Angioödemen, Myokardinfarkten (Herzinfarkten), rheumatroider Arthritis, Darmentzündungen, gramnegativer Sepsis, Ischämie-Reperfusion-Schädigung, Alzheimer und Schlaganfällen.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 18, 2026

    Agent’s address changed

    Representative
    Wild Schnyder AG, Forchstrasse 30, Postfach, 8032 Zürich → Wild Schnyder AG, Giesshübelstrasse 62, 8045 Zürich

    Published in Swissreg on 18.02.2026

  2. Sep 1, 2020

    Agent removed

    Representative
    WEINMANN ZIMMERLI, Apollostrasse 2, Postfach 1021, 8032 Zürich (removed)

    Published in Swissreg on 01.09.2020

  3. Sep 1, 2020

    Agent entered

    Representative
    Wild Schnyder AG, Forchstrasse 30, Postfach, 8032 Zürich

    Published in Swissreg on 01.09.2020

  4. Sep 1, 2020

    Holder’s address changed

    Owner
    ViroPharma Biologics, Inc., 300 Shire Way, Lexington, Massachusetts 02421, USA → ViroPharma Biologics LLC, 300 Shire Way, Lexington, Massachusetts 02421, USA

    Published in Swissreg on 01.09.2020

  5. Sep 15, 2017

    Holder’s address changed

    Owner
    ViroPharma Biologics, Inc., 730 Stockton Drive, Exton, Pennsylvania 19341, USA → ViroPharma Biologics, Inc., 300 Shire Way, Lexington, Massachusetts 02421, USA

    Published in Swissreg on 15.09.2017

  6. Sep 15, 2017

    Agent entered

    Representative
    Walder Wyss AG, Seefeldstrasse 123, Postfach 1236, 8034 Zürich → WEINMANN ZIMMERLI, Apollostrasse 2, Postfach 1021, 8032 Zürich

    Published in Swissreg on 15.09.2017

  7. Sep 15, 2017

    Renewed

    Published in Swissreg on 15.09.2017

  8. Jun 6, 2012

    Merged

    Owner
    Lev Pharmaceuticals, Inc., 675 3rd Avenue, Suite 2200, 10017 New York, NY, USA → Lev Development Corp., 730 Stockton Drive, Exton, Pennsylvania 19341, USA

    Published in Swissreg on 06.06.2012

4 earlier entries
  1. Jun 6, 2012

    Holder’s address changed

    Owner
    Lev Development Corp., 730 Stockton Drive, Exton, Pennsylvania 19341, USA → ViroPharma Biologics, Inc., 730 Stockton Drive, Exton, Pennsylvania 19341, USA

    Published in Swissreg on 06.06.2012

  2. Jan 24, 2011

    Agent’s address changed

    Representative
    Walder Wyss & Partner AG, Seefeldstrasse 123, Postfach 1236, 8034 Zürich → Walder Wyss AG, Seefeldstrasse 123, Postfach 1236, 8034 Zürich

    Published in Swissreg on 24.01.2011

  3. Jul 1, 2008

    Agent’s address changed

    Representative
    Walder Wyss & Partner, Seefeldstrasse 123,, Postfach 1236, 8034 Zürich → Walder Wyss & Partner AG, Seefeldstrasse 123, Postfach 1236, 8034 Zürich

    Published in Swissreg on 01.07.2008

  4. Apr 15, 2008

    Registered

    Published in the SOGC no. 72 of 15.04.2008

Parties

Holder

ViroPharma Biologics LLC

300 Shire Way, Lexington, Massachusetts 02421, US

Agent

Wild Schnyder AG

Giesshübelstrasse 62, 8045 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.